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To the editor: We wish to offer some cautionary remarks 
concerning the report by de Graaf et al. [1] about the 
first human tick-borne encephalitis (TBE) infection in 
the Netherlands, acquired in June 2016 (and not in July, 
as incorrectly mentioned in the title). At first sight, this 
case, apparently proven by ELISA and confirmed by 
neutralisation tests (NT), seems extremely convincing, 
especially as it occurred after a bite from a local tick 
(species not mentioned) that was later found by qRT-
PCR to be infected with a recently discovered Dutch 
TBE virus (TBEV).
However, this case could only be called 100% water-
proof, if (i) the Eurosurveillance reader was given veri-
fiable taxonomic data about the novel Salland TBEV 
and its relationship with other pathogenic TBEV and 
(ii) a convincing degree of homology was demon-
strated between the TBEV isolated from the tick and 
the patient. Neither of these conditions was fulfilled 
in this Rapid communication. Admittedly, condition 
(ii), although an unquestionable paradigm for zoonotic 
infections, will be hard to fulfil in any forthcoming TBE 
case because TBEV is nearly always cleared from blood 
and cerebrospinal fluid (CSF) already at the start of the 
second TBE phase, i.e. before the patient is admitted 
with neurologic complications [2,3]. Consequently, and 
against our own expectations, RT-PCR has not become 
the ultimate tool for physicians attending a putative 
TBE case [4], as was again demonstrated in this case.
Thus, physicians have to rely solely on serologi-
cal techniques, which have a number of flaws: TBEV 
shares common antigenic sites in its E protein with 
several other pathogenic flaviviruses, resulting in 
false-positive results in IgG and even IgM ELISA [2,4-
7]. The ELISA seropositivity in the presented case could 
thus in theory be ascribed to the patient’s yellow fever 
vaccination 11 years earlier [2,6,7]. Moreover, the spec-
ificity of gold standard NT, considered hitherto as sac-
rosanct, has recently also been called into question: in 
an animal study, four of five louping ill–infected sheep 
and two of 17 sera from West Nile virus (WNV)-infected 
horses, collected in TBE non-endemic regions and 
tested at British and German reference laboratories, 
reacted positive in TBE ELISA and even in TBE NT [7].
There are however still other, and more obvious, 
question marks concerning the evidence of true TBEV 
infection in the case under discussion. Firstly, two 
titres obtained in the NT remained unchanged (1/640). 
Although the crucial interval in days is not exactly 
specified (on days 24 and 36?), serological immobility 
is surprising for acute TBE when neutralising antibod-
ies can be expected to increase. It is however compat-
ible with a status of post-vaccination cross-protection. 
Secondly, and most importantly, CSF was only IgG-
positive, while IgM was lacking. IgM-positivity in CSF is, 
however, paramount for diagnosing TBE and other fla-
viviral infections such as West Nile fever, to the extent 
that CSF IgG is not even considered, nor required for 
diagnosis, certainly not in a patient with prior contact 
with flaviviruses [2]. Moreover, IgM-positivity in CSF is 
almost invariably present by the 10th day of TBE illness 
[2] and peaking between day 9 and week 6 [3].
Finally, CSF findings are supportive of TBE diagnosis, 
when there is (i) pleocytosis with predominance of 
segmented granulocytes over lymphocytes, (ii) impair-
ment of the blood–CSF barrier (increased CSF/serum 
albumin ratio), and (iii) intrathecal synthesis of immu-
noglobulins, predominantly of IgM [2]. None of these 
techniques were applied in the current case. As for 
the pleocytosis, an almost exclusive mononuclear cell 
reaction was found, which, to our knowledge, is highly 
unusual for TBE.
Since CSF, for unclear reasons, remained only IgG-
positive, determining the CSF/serum IgG ratio could be 
helpful in proving or disproving the TBE origin of this 
diagnostically challenging case.
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